Abelacimab Prevents VTE After Total Knee Arthroplasty

MONDAY, July 26, 2021 -- For patients undergoing total knee arthroplasty, abelacimab, a monoclonal antibody that binds to factor XI and locks it in the zymogen conformation, is effective for preventing venous thromboembolism without increasing the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news